Atara Biotherapeutics, Inc. (ATRA) Social Stream
Atara Biotherapeutics Inc (ATRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Atara Biotherapeutics Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-24 | 5 | $31 | $24 | $27.5 | $15.25 | 80.33% |
| 2021-11-04 | 7 | $31 | $26 | $27.8 | $15.25 | 82.3% |
| 2021-12-09 | 7 | $31 | $26 | $28 | $15.25 | 83.61% |
| 2021-12-13 | 6 | $31 | $26 | $28 | $15.25 | 83.61% |
| 2021-12-15 | 5 | $31 | $24 | $27.25 | $15.25 | 78.69% |
| 2021-12-15 | 6 | $31 | $24 | $27.25 | $15.25 | 78.69% |
The Trend in the Analyst Price Target
Over the past 170 days, ATRA's average price target has gone down $7.79.
Over the past 51 weeks, ATRA's average upside potential has been 121.35%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-22 | 11 | 78 | 10 | 35.29 | 13.77 | 156.28% |
| 2021-03-20 | 7 | 78 | 10 | 35.57 | 15.04 | 136.5% |
| 2021-02-06 | 11 | 78 | 9 | 32.89 | 20.32 | 61.86% |
| 2021-04-25 | 6 | 78 | 10 | 35.57 | 14.14 | 151.56% |
| 2021-07-10 | 11 | 78 | 10 | 35.29 | 14.15 | 149.4% |
ATRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 61 days, ATRA's average broker recommendation rating improved by 0.29.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Atara Biotherapeutics Inc's variance in analysts' estimates is lower than -61.45% of them.
- ATRA has a greater number of analysts covering the stock than 461.86% of stocks in the small market cap category.
- In the context of Pharmaceutical Products stocks, Atara Biotherapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 164.53% of them.
- In the context of stocks in the small market cap category, Atara Biotherapeutics Inc's average analyst price target is higher than 375.73% of them.
In the Pharmaceutical Products industry, ATHA, APTO, and AMAM are the three stocks most similar to Atara Biotherapeutics Inc regarding the price target and analyst recommendation information presented here.
Is ATRA a Buy, Hold or Sell? See the POWR Ratings now!